Research

AI Analysis of PET/CT Images can Predict Side Effects of Immunotherapy in Lung Cancer

Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI) can predict the occurrence of interstitial lung disease, known as a serious side effect of immunotherapy in lung cancer.

Immunotherapy has dramatically improved the treatment outcomes of primary lung cancer; however, it sometimes causes a serious side effect called interstitial lung disease.

New Medical AI Tool Identifies more Cases of Long COVID from Patient Health Records

Investigators at Mass General Brigham have developed an AI-based tool to sift through electronic health records to help clinicians identify cases of long COVID, an often mysterious condition that can encompass a litany of enduring symptoms, including fatigue, chronic cough, and brain fog after infection from SARS-CoV-2. The results, which are published in the journal Med, could identify more people who should be receiving care for this potentially debilitating condition. The number of cases they identified also suggests that the prevalence of long COVID could be greatly underrecognized.

A "Chemical ChatGPT" for New Medications

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of ChatGPT for molecules. Following a training phase, the AI was able to exactly reproduce the chemical structures of compounds with known dual-target activity that may be particularly effective medications. The study has now been published in Cell Reports Physical Science.

AI for Real-Rime, Patient-Focused Insight

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT.

Covered recently in the prestigious journal Nature Medicine, BiomedGPT is a new a new type of artificial intelligence (AI) designed to support a wide range of medical and scientific tasks.

New Research Shows Promise and Limitations of Physicians Working with GPT-4 for Decision Making

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied how well doctors used GPT-4 - an artificial intelligence (AI) large language model system - for diagnosing patients.

The study was conducted with 50 U.S.-licensed physicians in family medicine, internal medicine and emergency medicine.

New AI Tool Predicts Protein-Protein Interaction Mutations in Hundreds of Diseases

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication.

The computational tool is called PIONEER (Protein-protein InteractiOn iNtErfacE pRediction). Researchers demonstrated PIONEER's utility by identifying potential drug targets for dozens of cancers and other complex diseases in a recently published Nature Biotechnology article.

Wearable Cameras Allow AI to Detect Medication Errors

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery.

In a test whose results were published today, the video system recognized and identified, with high proficiency, which medications were being drawn in busy clinical settings.

More eHealth News ...